Sagility India shares jump 5.8% post lacklustre listing

Shares of healthcare services provider Sagility India jumped 5.8% to as much as Rs 32.87 after making a lacklustre listing. The stocks made a lacklustre debut on the stock market today, listing at a modest 3.53% premium at Rs 31.06 on the National Stock Exchange (NSE) while remaining flat at Rs 30 on the Bombay Stock Exchange (BSE).

Listing Details

In an official notice, BSE announced, “Trading Members of the Exchange are hereby informed that effective from Tuesday, November 12, 2024, the equity shares of Sagility India Limited shall be listed and admitted to dealings on the Exchange in the list of ‘B’ Group of Securities.” 

IPO Performance

The Sagility India IPO, which opened for subscription between November 5 and November 7, received a moderate response from investors. As per data from the NSE, the public issue was subscribed 3.20 times overall. 

Also Read Godrej Properties’ net debt rises 2% to Rs 7,572 crore in Q2, plans to raise Rs 6,000 crore for future growth Sagility India allotment on November 08; Here’s a step-by-step guide to check status Hindustan Zinc shares plunge over 7% after government announces 2.5% stake sale via OFS Premier Energies rises 8% as subsidiaries bag multiple orders worth Rs 560 crore

Breaking down by investor categories, the IPO received 4.16 times subscription in the Retail category, 3.52 times in the Qualified Institutional Buyers (QIBs) category, and 1.93 times in the Non-Institutional Investors (NII) category.

Offer Details

The IPO was offered at a price band of Rs 28 to Rs 30 per share. At the upper end of this price range, the company raised Rs 2,106.60 crore through the book-built issue, which consisted entirely of an Offer for Sale (OFS) of 70.22 crore equity shares. 

Lead Managers 

ICICI Securities, IIFL Securities, Jefferies India, and JP Morgan India acted as the book-running lead managers for the issue, while Link Intime India Private Ltd served as the IPO registrar. 

Also ReadSagility India to list today: Here are 4 things to know ahead of listing

Financial Performance of Sagility India

Sagility India reported a sharp 47.5% year-on-year decline in net profit to Rs 22.3 crore for the quarter ending June 2024, primarily driven by lower operating margins and a higher tax burden. 

 » Read More

Related Articles

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

Johnnie Walker-maker United Spirits posts Q3 profit decline of 4.29% to Rs 335 crore, revenue up 11.06% YoY

United Spirits, which makes Smirnoff vodka, on Thursday reported a profit of Rs 335 crore for the third quarter of FY25, posting a decline of 4.29 per cent in comparison to Rs 350 crore during the corresponding quarter of previous financial year. It posted revenue from operations at Rs 7,732 crore, reporting a growth of

Q3FY25: Mankind Pharma’s revenue up by 24 percent to Rs 3,230 Crore; Profit at Rs 380 crore

Pharma major Mankind Pharma on Thursday reported its financial results for the third quarter and nine months ended 31 st December 2024. The company reported revenue from Operations at Rs. 3,230 Cr, up by 24% YoY and domestic revenue at INR 2,773 Cr, up 17%, Exports at INR 457 Cr, up 121% YoY. The company’s